CLADIN- CLADribine and INnate immune response in multiple sclerosis - A phase IV prospective study.
Monif M, Sequeira RP, Muscat A, Stuckey S, Sanfilippo PG, Minh V, Loftus N, Voo V, Fazzolari K, Moss M, Maltby VE, Nguyen AL, Wesselingh R, Seery N, Nesbitt C, Baker J, Dwyer C, Taylor L, Rath L, Van der Walt A, Marriott M, Kalincik T, Lechner-Scott J, O'Brien TJ, Butzkueven H.
Monif M, et al. Among authors: nesbitt c.
Clin Immunol. 2024 Aug;265:110304. doi: 10.1016/j.clim.2024.110304. Epub 2024 Jul 2.
Clin Immunol. 2024.
PMID: 38964633
Clinical Trial.